| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2000 | CA2136226C Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia |
| 05/16/2000 | CA2129288C Phosphonooxymethyl esters of taxane derivatives |
| 05/16/2000 | CA2126752C Benzopyran and related ltb4 antagonists |
| 05/16/2000 | CA2116115C Sustained-release matrices for dental application |
| 05/16/2000 | CA2098893C Antioxidant composition of natural products and method of production thereof |
| 05/16/2000 | CA2081637C Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 05/16/2000 | CA2065286C Treatment of chronic inflammatory conditions |
| 05/16/2000 | CA2060865C Stable solid 2-octynyl adenosine and process for producing the same |
| 05/16/2000 | CA2053121C Pharmaceutical preparation based on lys-plasminogen |
| 05/16/2000 | CA2027276C Novel .alpha.-glucosidase inhibitors |
| 05/16/2000 | CA2018794C Crystalline cephem acid addition salts and processes for their preparation |
| 05/16/2000 | CA2013226C Cephalosporin derivatives and processes for their preparation |
| 05/16/2000 | CA2006778C Nifedipine pharmaceutical preparation |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/13/2000 | CA2289329A1 A suppressive agent against expression of cell adhesion molecules |
| 05/13/2000 | CA2289327A1 An anti-edema agent |
| 05/11/2000 | WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | WO2000026397A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 05/11/2000 | WO2000026396A1 A method of recombination and agents useful for same |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026384A1 Lps with reduced toxicity from genetically modified gram negative bacteria |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026254A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000026225A2 Nucleosides with anti-hepatitis b virus activity |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | WO2000026217A1 Imidazonaphthyridines |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 05/11/2000 | WO2000026211A1 Thrombin inhibitors |
| 05/11/2000 | WO2000026210A1 Thrombin inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 05/11/2000 | WO2000026204A1 Novel optically active aminopentane derivative |
| 05/11/2000 | WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026201A1 Benzoylpyridazines |
| 05/11/2000 | WO2000026199A2 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists |
| 05/11/2000 | WO2000026198A1 N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists |
| 05/11/2000 | WO2000026197A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 05/11/2000 | WO2000026185A2 Omeprazole solution and method of using same |
| 05/11/2000 | WO2000026174A2 Process for preparing natural product derivatives from plants in a single step |
| 05/11/2000 | WO2000026167A1 Vitamin d analogues |
| 05/11/2000 | WO2000025829A2 Radiodense compositions |
| 05/11/2000 | WO2000025825A1 Dds compounds and method for assaying the same |
| 05/11/2000 | WO2000025821A1 Method of treating and diagnosing restless legs syndrome and corresponding means |
| 05/11/2000 | WO2000025819A1 Enhanced radiation therapy |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025800A1 Steroid receptor rna activator |
| 05/11/2000 | WO2000025799A1 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION |
| 05/11/2000 | WO2000025798A1 Treatment of parkinson's disease with oligonucleotides |
| 05/11/2000 | WO2000025797A1 Combination therapy to treat hepatitis b virus |
| 05/11/2000 | WO2000025796A1 Treatment of asthma with fructose-1,6-diphosphate |
| 05/11/2000 | WO2000025795A1 Compositions comprising a mixture of bioflavonols |
| 05/11/2000 | WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 05/11/2000 | WO2000025793A1 Compositions for the treatment and prevention of neurological and pathopsychological diseases |
| 05/11/2000 | WO2000025792A1 Estradiol-containing adhesive preparation |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000025790A1 Controlled delivery of antidepressants |
| 05/11/2000 | WO2000025789A1 A method of treating endometriosis |
| 05/11/2000 | WO2000025788A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 05/11/2000 | WO2000025786A1 Heterocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025785A1 Plastics container containing stabilised drug formulations |
| 05/11/2000 | WO2000025784A1 Method for improving the pharmacokinetics of tipranavir |
| 05/11/2000 | WO2000025783A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 05/11/2000 | WO2000025782A1 Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists |
| 05/11/2000 | WO2000025781A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/11/2000 | WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 05/11/2000 | WO2000025779A1 Method of treating migraines and pharmaceutical compositions |
| 05/11/2000 | WO2000025778A1 5ht1 receptor agonists and metoclopramide for the treatment of migraine |
| 05/11/2000 | WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000025775A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 05/11/2000 | WO2000025774A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | WO2000025773A1 Pharmaceutical combination of mildronate and enalapril |
| 05/11/2000 | WO2000025772A1 Compositions of and process for producing isotretinoin having low particle size |
| 05/11/2000 | WO2000025771A1 Method for preventing increased iridial pigmentation during prostaglandin treatment |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025769A1 Analgesic regimen |
| 05/11/2000 | WO2000025767A2 Use of triphenylbutene derivatives for the treatment of neurological disorders |
| 05/11/2000 | WO2000025766A2 Use of nk antagonist for treating gastric asthma |
| 05/11/2000 | WO2000025765A2 Aqueous drug formulation for oral application |
| 05/11/2000 | WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 05/11/2000 | WO2000025763A2 Agents containing phenol derivatives having an inhibiting effect on the proliferation of tumour cells |
| 05/11/2000 | WO2000025758A1 Oral administration of adenosine analogs |
| 05/11/2000 | WO2000025754A2 Solid oral dosage forms containing alginic acid and famotidine |
| 05/11/2000 | WO2000025753A2 Controlled delivery of active agents |
| 05/11/2000 | WO2000025752A1 Multiparticulate modified release composition |
| 05/11/2000 | WO2000025750A1 Controlled-release formulations of metamizole |
| 05/11/2000 | WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 05/11/2000 | WO2000025744A1 Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| 05/11/2000 | WO2000025740A1 Topical compositions for enhancing glutathione production |